HUE032165T2 - N-actil-béta-alanin alkalmazásának módjai - Google Patents

N-actil-béta-alanin alkalmazásának módjai Download PDF

Info

Publication number
HUE032165T2
HUE032165T2 HUE12771428A HUE12771428A HUE032165T2 HU E032165 T2 HUE032165 T2 HU E032165T2 HU E12771428 A HUE12771428 A HU E12771428A HU E12771428 A HUE12771428 A HU E12771428A HU E032165 T2 HUE032165 T2 HU E032165T2
Authority
HU
Hungary
Prior art keywords
alanine
beta
acetyl
beta alanine
aktiv
Prior art date
Application number
HUE12771428A
Other languages
English (en)
Inventor
Ronald Kramer
Alexander Nikolaidis
Original Assignee
Thermolife Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47006851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE032165(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thermolife Int Llc filed Critical Thermolife Int Llc
Publication of HUE032165T2 publication Critical patent/HUE032165T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (5)

ΝβΛίίΜMM; ÂlMïrÂMSÂlMiv Mùmm ixabasiahsí í$éaygx»U<&amp;
1. KisÂêay sdslblipás äääs â|{s$ip:«^8lUKény tokox&amp;sâba*» arsely kmkméîsv N-acefib >X m da'xo h.*'C' isxnsx «s*ÿs s 5 vrt&amp;föxeva v*dkd fö'ps rsv.
VkhdMPm p««"< >«dr ''U> S Κ.ΛΐίΜχΜνίοΐ! π « '“î'î vdoP* w Mid*,; -^;· dk'Ukv^ <eM'‘kxi\x MoM^nty ;xx kïk hog> srd· psmrrédát okozna.
3. Késx«inên^.à»ely bföaedtl^m'Siläsu· £y%v*saat«ag kaâsos fnemayisé&amp;iH tæn&amp;Èma&amp;ïa, gyógy v.3r-k<-ot történő alk&amp;ÎHî&amp;Âra bë?&amp;-akn«> abszorpciójának és. s<sJlîOômbréô^ïnj«sà>iiit&amp;iàRâk Elativ őiíföztö #·. mr< rraoszport áftaK »oráéáföm, e/à&amp;é ewberbôa è< állasbanm. Mmlsljexhnföny foko^lsáM« andkól feogy tî^ilé^s^M«ïii:|^ïeÂaiàî ok>»»&amp;.
4. N«açenbbèta»aten gyégys.;«îrkàni rörtöaő föMmasások * kövsrtkozfc törőprás ésA-agy n*g«i&amp;xâ toc-Msrsí fsssziv dlfei /aktiv b&amp;sszpM ékstL MpsMo Mta-aianm «Μχοφοΐό *K »«jtmmbrân-pettÂIfl!^· ®?J'tthi Viharban és áliátbsa m &amp;ömt«|sslímá5y àitessâss s«éÉils 'S^::ï»eHèkhs{àskêm'.^ô^é okozrur
5. Eljárás b&amp;a-alsma absytfrpcsőjaaaL &amp; &amp;ej^«mbràa»p»rm«!ôbiiiütsà»éâ£' jpassaâv- bílEMás ás akov irm%zpun âh&amp;h ibküæâsâra« c^âiiai emberben «s âttetba« aEsHkus^ports^EestoÄfs^liteisa· saîslkib bogy mclk-i.hnuWkéet p^osatöziát öksabas .'.ta* ,t <!.-' I so' ' ïi.'\ sag' áihí'vK iibiâssIra^ïîÿpxïsElly Mbb5p1;sk||ks;:&amp;lfj|a gy|gy§gs«iÍ3g: InUákony ^enayíségd íá^Sííöiá^k:#í^%·· bcis jelenlévő hem-danln fök-idkiejének dVdeVbeí· íbrídfö dkdnnmáxrce esábd enn-erben es állatban ez <' kljpsl \ Λ' ím l u‘‘ I > V ' <A' >. i X v k Sf 'kv ti '% bj <&amp; „írbbota'S'amn g\og\ayufc»b»t törv v> tkaH^a^fa, .*s.<aráía»ib«n. jéjéktáy'é: bébiyakágh : föléseudvbéod; »uaeiése terápiás éV vsgy taagalözd kezdésben. e rábai emKroeí· e\> à! Un ban -tr s^^ivbesk' óíépy íbbüéása anélkül, hogy nKdkíkhaíáshéoí parészîézüî nkczna B. Eljárás véráramba«! jelenlévő báts-sMm föléld ideiéi növelésére, erálta! emberben és aïïaîban sa gEÄwsporsteljesifmdky ft^|[S5i ^8ÍMUkb^»lfö^a»á5ként arn^Jy magábaa h>gkdj» N*acehi-bek>-tdanin ha(ûs«s πκίϊλχ i;-.-.ígáoek hissbSsd a.-: «»sbersíík vagy áüatsrnk.
HUE12771428A 2011-04-13 2012-04-13 N-actil-béta-alanin alkalmazásának módjai HUE032165T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161475179P 2011-04-13 2011-04-13
US13/446,416 US8802731B2 (en) 2011-04-13 2012-04-13 N-acetyl beta alanine methods of use

Publications (1)

Publication Number Publication Date
HUE032165T2 true HUE032165T2 (hu) 2017-09-28

Family

ID=47006851

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12771428A HUE032165T2 (hu) 2011-04-13 2012-04-13 N-actil-béta-alanin alkalmazásának módjai

Country Status (8)

Country Link
US (3) US8802731B2 (hu)
EP (1) EP2696865B1 (hu)
AU (1) AU2012242565B2 (hu)
CA (1) CA2833159C (hu)
HU (1) HUE032165T2 (hu)
PL (1) PL2696865T3 (hu)
WO (1) WO2012142474A2 (hu)
ZA (1) ZA201308467B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2903000C (en) 2013-01-28 2021-10-12 Hector L. Lopez Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1916983A (en) 1933-07-04 Gas bubneb
US2176144A (en) 1939-02-04 1939-10-17 Corn Prod Refining Co Method of curing meat
US2553533A (en) 1950-06-17 1951-05-15 Griffith Laboratories Curing process for bacon
US3230036A (en) 1963-09-18 1966-01-18 Frederick A Kappelmann Method for separating americium and curium from the lanthanide rare earths and yttrium
IL25140A (en) 1965-02-15 1970-01-29 Vaessen Schoemaker Holding Bv Additives and methods for improving the quality of protein containing nutrients
DK119643C (da) 1965-04-12 1978-03-13 Ajinomoto Kk Middel til behandling af kod,fortrinsvis i ra tilstand,til forbedring af dets saftighed,farve og morhed
US3997659A (en) 1971-03-30 1976-12-14 The Procter & Gamble Company Hair bleaching compositions containing an arginine compound
JPS531832B2 (hu) 1972-07-03 1978-01-23
US4113715A (en) 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
IE51711B1 (en) 1977-11-03 1987-03-04 Sigma Tau Ind Farmaceuti Carnitine derivatives
US4379177A (en) 1979-07-05 1983-04-05 The Procter & Gamble Company Stable dehydrated cocrystalline amino acid food additives
US4687782A (en) 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
AU5410786A (en) 1985-03-04 1986-09-11 Fujisawa Pharmaceutical Co., Ltd. Amino acid derivatives and processes for preparation thereof
US4871550A (en) 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
IL80783A0 (en) 1986-10-17 1987-02-27 Univ Bar Ilan Food supplements
EP0351760B1 (en) 1988-07-19 1994-12-28 Mitsubishi Kasei Corporation Feed additive for ruminants
US5026721A (en) 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5026071A (en) 1990-03-05 1991-06-25 Miraglia Jr Humbert G Word game
CN1049824A (zh) 1990-03-25 1991-03-13 何森 水彩笔芯
CN1022456C (zh) 1990-05-04 1993-10-20 师春生 一种高能营养滋补饮料的制造方法
US5242697A (en) 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
DE4125400C2 (de) 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US6608109B2 (en) 1991-11-20 2003-08-19 Allen Ann De Wees Composition comprising L-arginine as a muscle growth stimulant and use thereof
DE4222980A1 (de) 1992-07-13 1994-01-20 Cassella Ag Verwendung von 2-(N-(2-Aminoethyl)amino)-essigsäure-derivaten
US5631031A (en) 1994-06-13 1997-05-20 Meade; Thomas L. Water-insoluble amino acid salt
US6239172B1 (en) 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
US20110196039A9 (en) 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US5543430A (en) 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1291134B1 (it) 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
DK176196B1 (da) 1997-10-07 2007-01-08 Ejvind Jersie Pedersen Mundhygejnepræparat til behandling af halitosis samt anvendelse af et chelat omfattende en metaliondel og en aminosyredel som en komponent i præparatet
US5904924A (en) 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6063432A (en) 1998-05-19 2000-05-16 Cooke Pharma Arginine or lysine containing fruit healthbar formulation
US6277884B1 (en) 1998-06-01 2001-08-21 Nitromed, Inc. Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
WO2000069470A2 (en) 1999-05-17 2000-11-23 Aesgen, Inc. Improved cellular uptake of bioactive agents
GB2354441A (en) 1999-08-06 2001-03-28 Mccormack Ltd Composition for treating dentine hypersensitivity
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6784209B1 (en) 1999-10-18 2004-08-31 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
US7235237B2 (en) 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
IL149907A0 (en) 1999-12-16 2002-11-10 Mark Nutritionals Inc Nutritional composition, methods of producing said composition and methods of using said composition
US20020006532A1 (en) 2000-04-26 2002-01-17 Arnaud Robin Bonded LTD-resistant zirconia dental components
US6812215B2 (en) 2000-06-02 2004-11-02 MERCK Patent Gesellschaft mit beschränkter Haftung Compositions for the treatment of inflammatory joint diseases and osteoporosis
WO2001095897A1 (en) 2000-06-15 2001-12-20 University Of Kentucky Research Foundation Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
US20020176881A1 (en) 2001-01-26 2002-11-28 George Verlaan Rehydration composition
US6859771B2 (en) 2001-04-23 2005-02-22 Microsoft Corporation System and method for identifying base noun phrases
US20040097401A1 (en) 2002-11-14 2004-05-20 Debatosh Datta Lysine in therapeutic angiogenesis, particularly in treating ischaemic conditions
ITRM20010445A1 (it) 2001-07-25 2003-01-27 Sigma Tau Healthscience Spa Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
US7740878B2 (en) 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
US7054925B2 (en) 2001-11-21 2006-05-30 International Business Machines Corporation Efficient method for determining record based I/O on top of streaming protocols
WO2003063789A2 (en) 2002-01-30 2003-08-07 House Ear Institute L-carnitine for treatment of hearing loss
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
US20040057926A1 (en) 2002-03-12 2004-03-25 Lsu Medical Center Modulation of the immune response through the manipulation of arginine levels
EP1567180A4 (en) 2002-06-04 2010-03-10 Avicena Group Inc METHODS OF TREATING COGNITIVE DYSFUNCTIONS BY MODULATING BRAIN ENERGY METABOLISM
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
WO2005035001A1 (en) 2003-09-29 2005-04-21 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
KR20050083827A (ko) 2002-10-24 2005-08-26 이노스 파마슈티칼스, 인코포레이티드 서방성 ｌ-아르기닌 포뮬레이션 및 이의 제조방법 및 용도
US20050288373A1 (en) 2002-10-24 2005-12-29 Ron Eyal S Methods of treating various conditions by administration of sustained release L-arginine
US20060029668A1 (en) 2002-10-24 2006-02-09 Ron Eyal S Sustained release L-arginine formulations and methods of manufacture and use
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
DE60332163D1 (de) 2002-12-27 2010-05-27 Daiichi Sankyo Healthcare Co Zusammensetzung zur hautaufhellung
JPWO2004064866A1 (ja) * 2003-01-20 2006-05-18 イノヴェイティブ ヴィジョン プロダクツ インコーポレーテッド カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
US20050043274A1 (en) 2003-08-22 2005-02-24 Howard Murad Pharmaceutical compositions and methods for lowering blood pressure and pulse rate
US20050053673A1 (en) 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US20050136509A1 (en) 2003-09-10 2005-06-23 Bioimagene, Inc. Method and system for quantitatively analyzing biological samples
WO2005055947A2 (en) * 2003-12-08 2005-06-23 Yu Ruey J Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
WO2005062713A2 (en) 2003-12-31 2005-07-14 Yosi Shevach Beta vulgaris-based products
JP4813023B2 (ja) 2004-03-03 2011-11-09 日本新薬株式会社 保健食品、及び薬剤
CA2564886A1 (en) 2004-04-30 2005-11-17 Pump Formulations, Ltd. Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
GB0411985D0 (en) 2004-05-28 2004-06-30 Howard Foundation Holdings Ltd Food compositions containing creatine
US7362274B1 (en) 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7873012B2 (en) 2004-07-26 2011-01-18 Avaya Communication Israel Ltd. Roaming wireless client communication
CA2579032C (en) 2004-09-02 2011-11-29 Cosmo Oil Co., Ltd. Use of an .delta.-amino acid as thymocyte growth agent
CN1631539A (zh) 2004-12-03 2005-06-29 北京大学 氨基酸盐离子液体及其制备方法
US20070141174A1 (en) 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
CA2537647A1 (en) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
WO2006127761A1 (en) 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
WO2007000985A1 (ja) 2005-06-27 2007-01-04 Kyowa Hakko Kogyo Co., Ltd. ヘモグロビン尿症またはミオグロビン尿症の予防または治療用組成物
US20070105817A1 (en) 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
CN101340905B (zh) 2005-12-05 2012-05-16 协和发酵生化株式会社 用于防止或改善皮肤干燥的口服制剂
EP1889625A1 (en) 2006-07-17 2008-02-20 Pharmaton S.A. Dietary supplement for supporting mental and physical performance
CA2609626A1 (en) 2006-12-06 2008-02-05 H3 Formulations Ltd. Composition comprising l-arginine, crataegus, artichoke flavonoids and citruilline for improving blood flow in working muscles
EP2114417A4 (en) 2007-02-26 2014-04-02 Heartbeet Ltd NOVEL USE OF NITRATES AND NITRATES AND COMPOSITIONS COMPRISING THE SAME
EP3159000A1 (en) 2007-02-26 2017-04-26 HeartBeet Ltd. Performance enhancing composition
US7850997B2 (en) 2007-03-21 2010-12-14 Tim Romero Dietary compositions and methods of enhancing lean body mass and exercise performance
EP1982604A1 (de) 2007-04-20 2008-10-22 Naturheilzentrum Allgäu Nahrungsergänzungsmittel zum Ausgleich von Nährstoffmangel
US8569369B2 (en) 2007-09-18 2013-10-29 Thermolife International, Llc Amino acid compounds
US8569368B2 (en) 2007-09-18 2013-10-29 Thermolife International, Llc Amino acid compounds
US7777074B2 (en) 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US8455531B2 (en) 2007-09-18 2013-06-04 Thermolife International, Llc Amino acid compositions
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US8048921B2 (en) 2007-09-18 2011-11-01 Ronald Kramer Amino acid compounds
US20090280199A1 (en) 2007-11-01 2009-11-12 Aaken Laboratories, Inc. Neuroprotective Compositions and Methods of Using Same
EP2303040A1 (en) 2008-06-06 2011-04-06 PhytoLab GmbH & Co. KG Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8916612B2 (en) 2008-09-11 2014-12-23 Gad Gilad Agmatine containing dietary supplements, nutraceuticals, and foods
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
KR20110015141A (ko) 2009-08-07 2011-02-15 주식회사 셀트리온제약 피페라진 다이티옥트산염 및 아세틸-ｌ-카르니틴을 포함하는 약제학적 조성물
US20110064720A1 (en) 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
US9271983B2 (en) 2010-03-26 2016-03-01 Bioadatp, Llc Composition for enhancing athletic performance
GB2523578A (en) 2014-02-28 2015-09-02 Daniel Nelson A nutritional supplement
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
EP3975754A1 (en) 2019-05-28 2022-04-06 Mayo Foundation for Medical Education and Research Nutritional health supplements

Also Published As

Publication number Publication date
WO2012142474A3 (en) 2012-12-27
AU2012242565B2 (en) 2017-05-11
EP2696865A2 (en) 2014-02-19
US8802731B2 (en) 2014-08-12
ZA201308467B (en) 2014-08-27
PL2696865T3 (pl) 2017-07-31
US20140350108A1 (en) 2014-11-27
US20140350109A1 (en) 2014-11-27
CA2833159A1 (en) 2012-10-18
AU2012242565A1 (en) 2013-11-07
US11534419B2 (en) 2022-12-27
WO2012142474A2 (en) 2012-10-18
EP2696865A4 (en) 2014-10-15
EP2696865B1 (en) 2016-12-21
CA2833159C (en) 2019-08-06
US20120264826A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
JP6077305B2 (ja) アミノ酸および植物を含む調製物およびアルコール解毒におけるその活性
US20060269617A1 (en) Supplement compositions and method of use for enhancement of insulin sensitivity
TWI517793B (zh) Contains the composition of imidazole peptides and quercetin glycosides
CA2556305A1 (en) Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity
JPH11500725A (ja) ピペリンのバイオアベイラビリティ増強剤としての使用
WO2008134645A1 (en) Compositions and approaches for increasing diet induced thermogenesis, inducing weight loss and maintaining muscles mass and strength
MX2010009015A (es) Extracto de hojas de especie panax, proceso para hacer el mismo y usos del mismo.
JP6441825B2 (ja) フィラーの効能維持用組成物
US20080076721A1 (en) Use of branched chain fatty acid amino acid salts and compositions thereof
JP4253296B2 (ja) 健康美容食品
US11534419B2 (en) N-acetyl beta alanine methods of use
JP6196847B2 (ja) 防已含有組成物
AU2011300376B2 (en) Ingredients derived from Sphaeranthus indicus
JP4011594B2 (ja) 安定性及び生物学的利用率が高められた複合体及びその製造方法
JP2009001507A (ja) 体脂肪減少剤およびその利用
AU2006347124B2 (en) Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genus Acacia
CA2878190A1 (en) Pharmaceutical composition for reducing the trimethylamine n-oxide level
JP5294194B2 (ja) 脳血管性認知症の治療薬
JP2004018446A (ja) 美肌用内服剤組成物
JPWO2009110464A1 (ja) 栄養改善用組成物
WO2002069956A2 (en) Use of carnitine for increasing testosteron